IRIS
PATRONE, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.226
AS - Asia 2.186
NA - Nord America 858
SA - Sud America 166
AF - Africa 37
OC - Oceania 8
Totale 27.481
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 23.861
SG - Singapore 986
US - Stati Uniti d'America 811
CN - Cina 569
VN - Vietnam 404
FR - Francia 180
BR - Brasile 94
HK - Hong Kong 67
DE - Germania 51
AR - Argentina 39
CH - Svizzera 28
IN - India 28
JP - Giappone 28
FI - Finlandia 27
GB - Regno Unito 22
MX - Messico 22
BD - Bangladesh 18
CA - Canada 15
IQ - Iraq 15
EC - Ecuador 14
ID - Indonesia 13
ZA - Sudafrica 13
PH - Filippine 12
RU - Federazione Russa 11
NL - Olanda 9
MA - Marocco 8
UZ - Uzbekistan 8
AU - Australia 7
ES - Italia 6
IE - Irlanda 6
TH - Thailandia 6
UA - Ucraina 6
TR - Turchia 5
CL - Cile 4
CO - Colombia 4
KE - Kenya 4
KR - Corea 4
KZ - Kazakistan 4
LT - Lituania 4
PK - Pakistan 4
AZ - Azerbaigian 3
PA - Panama 3
PL - Polonia 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SE - Svezia 2
AL - Albania 1
BE - Belgio 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
NG - Nigeria 1
PF - Polinesia Francese 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
YT - Mayotte 1
Totale 27.481
Salva come PNG Salva come JPEG
Città #
Genova 15.082
Genoa 5.089
Rapallo 2.204
Vado Ligure 1.289
Singapore 442
San Jose 358
Lauterbourg 174
Ho Chi Minh City 133
Ashburn 97
Hanoi 83
Beijing 70
Hong Kong 64
Milan 64
New York 58
Frankfurt am Main 44
Bordighera 42
Santa Clara 30
Zurich 28
Helsinki 27
Valenza 27
Tokyo 24
Da Nang 16
Council Bluffs 15
Los Angeles 14
Tianjin 14
Haiphong 13
Mexico City 13
Orem 13
Biên Hòa 12
Cardiff 9
Delhi 9
São Paulo 9
Amsterdam 8
Dallas 8
Rovereto 8
Buffalo 7
Hải Dương 7
Johannesburg 7
Ninh Bình 7
Baghdad 6
City of London 6
Des Moines 6
Montreal 6
Rome 6
Thái Bình 6
Buenos Aires 5
Can Tho 5
Chicago 5
Dublin 5
Mumbai 5
Nha Trang 5
Tashkent 5
Atlanta 4
Bình Phước 4
Cape Town 4
Denver 4
London 4
Nairobi 4
Paris 4
Quezon City 4
Quảng Ngãi 4
Rio de Janeiro 4
Shanghai 4
Sydney 4
Agadir 3
Baku 3
Casablanca 3
Guayaquil 3
Houston 3
Kyiv 3
Madrid 3
Melbourne 3
Nantong 3
Naples 3
Panama City 3
Quito 3
Shenzhen 3
Thái Nguyên 3
Toronto 3
Turin 3
Vĩnh Long 3
Vĩnh Tường 3
Warsaw 3
Wenzhou 3
Almaty 2
Amman 2
Antakya 2
Athens 2
Bangkok 2
Birmingham 2
Bogotá 2
Brooklyn 2
Bình Dương 2
Bắc Ninh 2
Cachoeira do Sul 2
Campinas 2
Carangola 2
Charlotte 2
Chennai 2
Cuenca 2
Totale 25.829
Salva come PNG Salva come JPEG
Nome #
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 266
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 258
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 252
APO866 activity in hematologic malignancies: a preclinical in vitro study. 245
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 245
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 243
Autophagy in blood cancers: biological role and therapeutic implications. 235
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 228
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 216
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 210
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 203
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 200
Ras-induced resistance to lapatinib is overcome by MEK inhibition 199
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 199
Anticancer vaccination strategies. 197
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 197
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 196
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 195
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 192
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 192
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 191
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 190
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 189
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 189
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 189
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 188
Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. 187
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 186
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 186
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 182
In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storage. 181
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. I. Specimens mounted in neutral resin]. 181
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 180
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 178
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 177
Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors 176
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 174
A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. 174
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 174
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 174
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 174
A simple acid-precipitation test for rapid screening of monoclonal gammopathies. 173
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 172
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 172
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 171
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 171
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 170
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 169
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 169
High-dose cyclophosphamide followed by gm-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells 168
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 167
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. II. Specimens mounted in neutral resin]. 166
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 165
Identification of mouse bone marrow colony growth in agar-cultures by the nitroblue tetrazolium dye. 164
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 163
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 160
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer 157
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 156
The use of dendritic cells in cancer immunotherapy. 156
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 155
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 154
In vitro effects of synthetic chemotactic peptides on neutrophil function. 153
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 153
[Cytochemical semiquantitative evaluation of peroxidase activity in blood cells. Method]. 152
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 149
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 148
New insights into biology of chronic myeloid leukemia: implications in therapy. 148
Autologous peripheral blood stem cells (PBSC) in breast cancer. 148
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 148
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 147
Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. 145
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 145
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells 144
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes. 144
Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. 143
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 143
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. 143
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 143
Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide and cisplatin (CEP) 142
Hyperimmunoglobulinemia E syndrome. 142
Neutrophil chemotaxis: physiology and pathology. 142
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor cell rescue for metastatic breast cancer 141
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity. 140
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial. 140
Monocyte-derived macrophages as helper cells in monocyte-mediated cytolysis. 139
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 138
New insights into the treatment of multiple myeloma with histone deacetylase inhibitors. 138
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer 136
Enhancement of the in vitro colony-forming capacity of human T lymphocytes induced by levamisole. 136
Defective neutrophil mobilization to skin chambers in cancer patients. 136
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. 136
Duplication of the der(13)t(12;13)(p13;q14) in chronic myelomonocytic leukemia. 135
Neutrophil functions in acne conglobata. 135
[Distribution of acid phosphatase activity in white blood cells]. 135
[Semiquantitative evaluation of leukocyte acid phosphatase]. 134
Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine. 134
Stimulation of neutrophil locomotion by inosiplex. 134
Effector-target co-aggregation as a crucial step in the neutrophil-mediated tumour cell lysis. 133
Phagocytosis-dependent neutrophil-mediated extracellular cytotoxicity against different target cells. 133
Augmentation of neutrophil-mediated erythrocyte lysis by cells derived in vitro from human monocytes. 133
Totale 16.994
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.714
article - articoli 74.116
book - libri 0
conference - conferenze 474
curatela - curatele 0
other - altro 0
patent - brevetti 149
selected - selezionate 0
volume - volumi 975
Totale 151.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 0 0 0 0 0 0 116 145 103
2021/20222.402 57 182 172 256 176 144 128 536 78 243 109 321
2022/20232.651 270 195 18 290 437 490 12 199 462 12 241 25
2023/20241.256 44 159 23 148 99 268 43 140 54 21 64 193
2024/20253.235 109 270 95 213 454 272 296 592 87 135 306 406
2025/20265.258 731 150 281 520 786 581 1.030 244 379 556 0 0
Totale 27.581